Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13 USD | +5.78% | -9.97% | -18.14% |
Apr. 25 | Top Premarket Gainers | MT |
Apr. 25 | North American Morning Briefing : More Tech -2- | DJ |
Financials (USD)
Sales 2024 * | 39.3M | Sales 2025 * | 45.96M | Capitalization | 56.06M |
---|---|---|---|---|---|
Net income 2024 * | -35M | Net income 2025 * | -19M | EV / Sales 2024 * | 1.43 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.22 x |
P/E ratio 2024 * |
-2.04
x | P/E ratio 2025 * |
-17.4
x | Employees | 69 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 1,836.91% |
Latest transcript on Cidara Therapeutics, Inc.
1 day | +5.78% | ||
1 week | -9.97% | ||
Current month | -29.35% | ||
1 month | -12.92% | ||
3 months | -3.70% | ||
6 months | -21.69% | ||
Current year | -18.14% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 13-12-31 |
Preetam Shah
DFI | Director of Finance/CFO | 51 | 21-08-31 |
Les Tari
CTO | Chief Tech/Sci/R&D Officer | 57 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Burgess
CHM | Chairman | 62 | 14-03-31 |
Director/Board Member | 69 | 14-03-31 | |
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 13-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 13 | +5.78% | 753,156 |
24-04-24 | 12.29 | +19.90% | 326,436 |
24-04-23 | 10.25 | -0.27% | 96,083 |
24-04-22 | 10.28 | -24.54% | 192,657 |
24-04-19 | 13.62 | -5.68% | 18,245 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.14% | 56.06M | |
-2.26% | 104B | |
+1.41% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.63% | 15.06B | |
+4.55% | 13.98B | |
+32.11% | 11.66B |
- Stock Market
- Equities
- CDTX Stock